Thermo Fisher Scientific Inc. (TMO) Stock Price: $483.01-11.06 (-2.24%)
At close: Wednesday, June 10, 2026
The total return CAGR for Thermo Fisher Scientific Inc. (TMO) stock is 16.97% over the past 12 months. The 3 year CAGR is -2.01% and the 5 year CAGR is 1.04%. Total return includes dividends reinvested.
The closing share price for Thermo Fisher Scientific Inc. (TMO) stock was $483.01 for Wednesday, June 10, 2026, down 2.24% from the previous day.
TMO Price Chart
TMO Key Metrics
See All MetricsTMO Earnings Preview
Next Earnings Date
Jul 22, 2026
41 days away
EPS Estimate
5.75
Revenue Est.
$11.71B
Last Quarter Results
EPS
$5.44
vs Estimate
$5.24
Revenue
$11.01B
vs Estimate
$10.86B
TMO Analyst Ratings
Consensus Rating
Based on 25 analysts
Average Price Target
$602.76
+24.8% upside
Low
$490.00
Current
$483.01
High
$750.00
TMO Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $5.96 | N/A | 7 |
| Q2 2027 | N/A | $6.36 | N/A | 6 |
| Q3 2027 | N/A | $6.96 | N/A | 6 |
| Q4 2027 | N/A | $7.92 | N/A | 11 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $27.20 | N/A | 15 |
| FY 2028 | N/A | $30.00 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $11.76B | N/A | — |
| Q2 2027 | N/A | $12.29B | N/A | — |
| Q3 2027 | N/A | $12.55B | N/A | — |
| Q4 2027 | N/A | $13.71B | N/A | — |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $50.36B | N/A | — |
| FY 2028 | N/A | $53.54B | N/A | — |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
TMO Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1TMO | $179.45B | $483.01 | -2.24% | +16.97% | +1.04% | +12.59% |
TMO Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper